TBPH · Theravance Biopharma, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-07 | Samaha Eli |
Director |
Sell↓
Filing footnotes — COM (Indirect)
The sales price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.17 to $17.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. |
COM
(I)
|
5,564 |
| 2026-07-06 | Samaha Eli |
Director |
Sell↓
Filing footnotes — COM (Indirect)
These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. |
COM
(I)
|
1,400 |
| 2026-07-01 | Samaha Eli |
Director |
Sell↓
Filing footnotes — COM (Indirect)
The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.00 to $17.015, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. |
COM
(I)
|
37,799 |
| 2026-06-30 | Samaha Eli |
Director |
Sell↓
Filing footnotes — COM (Indirect)
The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.13 to $17.145, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. |
COM
(I)
|
25,027 |
| 2026-06-29 | Samaha Eli |
Director |
Sell↓
Filing footnotes — COM (Indirect)
The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.07 to $17.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. |
COM
(I)
|
273,871 |
| 2026-06-19 | Miller Aine |
SVP, DEV & HEAD OF IRE OFFICE |
Award↑
|
Ordinary Shares
|
18,750 |
| 2026-06-15 | Farnum Rhonda |
SVP, COMM & MEDICAL AFFAIRS |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
This transaction was executed in multiple trades at prices from $16.21 to $16.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. |
Ordinary Shares
|
6,657 |
| 2026-06-15 | Farnum Rhonda |
SVP, COMM & MEDICAL AFFAIRS |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
This transaction was executed in multiple trades at prices from $16.21 to $16.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. |
Ordinary Shares
|
3,329 |
| 2026-06-15 | Farnum Rhonda |
SVP, COMM & MEDICAL AFFAIRS |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
This transaction was executed in multiple trades at prices from $16.21 to $16.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. |
Ordinary Shares
|
3,328 |
| 2026-06-12 | GRAY SUSANNAH |
Director |
Award↑
Filing footnotes — Share Option (Right to Buy) (Direct)
This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. |
Share Option (Right to Buy)
|
13,398 |
| 2026-06-12 | GRAY SUSANNAH |
Director |
Award↑
|
Ordinary Shares
|
6,009 |
| 2026-06-12 | O'Connor Donal |
Director |
Award↑
|
Ordinary Shares
|
6,009 |
| 2026-06-12 | O'Connor Donal |
Director |
Award↑
Filing footnotes — Share Option (Right to Buy) (Direct)
This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. |
Share Option (Right to Buy)
|
13,398 |
| 2026-06-12 | PAKIANATHAN DEEPIKA |
Director |
Award↑
|
Ordinary Shares
|
6,009 |
| 2026-06-12 | MITCHELL DEAN J |
Director |
Award↑
|
Ordinary Shares
|
6,009 |
| 2026-06-12 | Smaldone Alsup Laurie |
Director |
Award↑
Filing footnotes — Share Option (Right to Buy) (Direct)
This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. |
Share Option (Right to Buy)
|
13,398 |
| 2026-06-12 | Smaldone Alsup Laurie |
Director |
Award↑
|
Ordinary Shares
|
6,009 |
| 2026-06-12 | PAKIANATHAN DEEPIKA |
Director |
Award↑
Filing footnotes — Share Option (Right to Buy) (Direct)
This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. |
Share Option (Right to Buy)
|
13,398 |
| 2026-06-12 | MITCHELL DEAN J |
Director |
Award↑
Filing footnotes — Share Option (Right to Buy) (Direct)
This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date. |
Share Option (Right to Buy)
|
13,398 |
| 2026-05-20 | Miller Aine |
SVP, DEV & HEAD OF IRE OFFICE |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |
Ordinary Shares
|
6,827 |
| 2026-05-20 | Sawaf Aziz |
SVP & CHIEF FINANCIAL OFFICER |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |
Ordinary Shares
|
8,670 |
| 2026-05-20 | Grimaud Brett A. |
SVP, GEN COUNSEL AND SECRETARY |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |
Ordinary Shares
|
8,829 |
| 2026-05-20 | Winningham Rick E |
Director |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |
Ordinary Shares
|
20,038 |
| 2026-05-20 | Farnum Rhonda |
SVP, COMM & MEDICAL AFFAIRS |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |
Ordinary Shares
|
5,678 |
| 2026-04-01 | Winningham Rick E |
Director |
Award↑
|
Ordinary Shares
|
75,000 |
| 2026-04-01 | Sawaf Aziz |
SVP & CHIEF FINANCIAL OFFICER |
Award↑
|
Ordinary Shares
|
37,500 |
| 2026-04-01 | Farnum Rhonda |
SVP, COMM & MEDICAL AFFAIRS |
Award↑
|
Ordinary Shares
|
18,750 |
| 2026-04-01 | Grimaud Brett A. |
SVP, GEN COUNSEL AND SECRETARY |
Award↑
|
Ordinary Shares
|
37,500 |
| 2026-03-16 | Farnum Rhonda |
SVP, COMM & MEDICAL AFFAIRS |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
This transaction was executed in multiple trades at prices from $13.755 to $14.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. |
Ordinary Shares
|
7,766 |
| 2026-03-16 | Farnum Rhonda |
SVP, COMM & MEDICAL AFFAIRS |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
This transaction was executed in multiple trades at prices from $13.755 to $14.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. |
Ordinary Shares
|
7,767 |
| 2026-03-16 | Farnum Rhonda |
SVP, COMM & MEDICAL AFFAIRS |
Sell↓
|
Ordinary Shares
|
15,534 |
| 2026-02-20 | Sawaf Aziz |
SVP & CHIEF FINANCIAL OFFICER |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |
Ordinary Shares
|
20,672 |
| 2026-02-20 | Farnum Rhonda |
SVP, COMM & MEDICAL AFFAIRS |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |
Ordinary Shares
|
13,929 |
| 2026-02-20 | Grimaud Brett A. |
SVP, GEN COUNSEL AND SECRETARY |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |
Ordinary Shares
|
20,833 |
| 2026-02-20 | Winningham Rick E |
Director |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |
Ordinary Shares
|
74,975 |
| 2026-02-20 | Miller Aine |
SVP, DEV & HEAD OF IRE OFFICE |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |
Ordinary Shares
|
16,851 |
| 2025-12-03 | Farnum Rhonda |
SVP, COMM & MEDICAL AFFAIRS |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
This transaction was executed in multiple trades at prices from $18.52 to $18.94 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. |
Ordinary Shares
|
7,767 |
| 2025-12-03 | Farnum Rhonda |
SVP, COMM & MEDICAL AFFAIRS |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
This transaction was executed in multiple trades at prices from $18.52 to $18.94 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. |
Ordinary Shares
|
15,534 |
| 2025-12-03 | Farnum Rhonda |
SVP, COMM & MEDICAL AFFAIRS |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
This transaction was executed in multiple trades at prices from $18.52 to $18.94 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. |
Ordinary Shares
|
7,766 |
| 2025-11-26 | BROSHY ERAN |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024. |
Ordinary Shares
|
15,501 |
| 2025-11-26 | BROSHY ERAN |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The reporting person exercised stock options to acquire 14,000 Ordinary Shares and sold all such shares on the same day in a broker-assisted transaction. No shares were withheld for taxes. The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024. |
Ordinary Shares
|
14,000 |
| 2025-11-26 | BROSHY ERAN |
Director |
Convert↑
Filing footnotes — Share Option (Right to Buy) (Direct)
This Share Option was fully vested and exercisable (having vested as to 1/12th of the shares subject to the option upon completion of each continuous month of service following the original grant date and any remaining unvested shares vesting on the date of the next annual meeting of the company's shareholders provided continuous service through such date). Reflects solely exercisable, vested Share Options following reported transaction. |
Share Option (Right to Buy)
|
14,000 |
| 2025-11-20 | Grimaud Brett A. |
SVP, GEN COUNSEL AND SECRETARY |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |
Ordinary Shares
|
19,024 |
| 2025-11-20 | Sawaf Aziz |
SVP & CHIEF FINANCIAL OFFICER |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |
Ordinary Shares
|
18,627 |
| 2025-11-20 | Miller Aine |
SVP, DEV & HEAD OF IRE OFFICE |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |
Ordinary Shares
|
6,989 |
| 2025-11-20 | Farnum Rhonda |
SVP, COMM & MEDICAL AFFAIRS |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |
Ordinary Shares
|
9,060 |
| 2025-11-20 | Winningham Rick E |
Director |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |
Ordinary Shares
|
56,817 |
| 2025-11-19 | Winningham Rick E |
Director |
Gift↑
Filing footnotes — Ordinary Shares (Indirect)
Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA"), for which the Reporting Person serves as a custodian. The shares are held for grandchildren of the Reporting Person through a UTMA account, for which the Reporting Person serves as custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his grandchildren's shares for purposes of Section 16 or for any other purpose. |
Ordinary Shares
(I)
|
9,900 |
| 2025-11-19 | Winningham Rick E |
Director |
Gift↓
Filing footnotes — Ordinary Shares (Direct)
Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA"), for which the Reporting Person serves as a custodian. |
Ordinary Shares
|
9,900 |
| 2025-11-11 | BROSHY ERAN |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024. |
Ordinary Shares
|
15,500 |